Atrophy of the brain grey matter (GM) is an accepted and important feature of multiple
sclerosis (MS). However, its accurate measurement is hampered by various technical …

Brain atlases and templates are at the heart of neuroimaging analyses, for which they
facilitate multimodal registration, enable group comparisons and provide anatomical …

Brain volumetric measurements in multiple sclerosis (MS) reflect not only disease-specific
processes but also other sources of variability. The latter has to be considered especially in …

Multiple sclerosis lesions influence the process of image analysis, leading to tissue
segmentation problems and biased morphometric estimates. Existing techniques try to …

The cerebral cortex is a highly folded outer layer of grey matter tissue that plays a key role in
cognitive functions. In part, alterations of the cortex during development and disease can be …

Background Volume loss in the deep gray matter (DGM) has been reported in patients with
multiple sclerosis (MS) already at early stages of the disease and is thought to progress …

Background and Objective: Olfactory dysfunction (hyposmia) is an important non-motor
symptom of Parkinson's disease (PD). To investigate the potential prognostic value of …

Over the last few years, the increasing interest in brain tissue volume measurements on
clinical settings has led to the development of a wide number of automated tissue …

Purpose: The main goal of this study is to investigate the discrimination power of Grey Matter
(GM) thickness connectome data between Multiple Sclerosis (MS) clinical profiles using …

Background and purpose In an era of individualized multiple sclerosis (MS) patient
management, biomarkers for accurate prediction of future clinical outcomes are needed. We …